Drugs / Tice-strain BCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00696579 Comparator | Jan 2004 → Mar 2008 | urinary bladder cancer | University Of Perugia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tice-strain BCG | “6 weekly instillations of Tice-strain BCG (Organon Teknika Corp.) as induction chemotherapy, with a dose of 5 x 108 CFU diluted in 50 mL of saline held in the bladder for 2 hours.” NCT00696579 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00696579 ↗ |
| Route | Other | “6 weekly instillations of Tice-strain BCG (Organon Teknika Corp.) as induction chemotherapy, with a dose of 5 x 108 CFU diluted in 50 mL of saline held in the bladder for 2 hours.” NCT00696579 ↗ |